Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site




ELI LILLY AND COMPANY (LLY)

The QuantWave forecast for LLY eli lilly and company

Eli Lilly and Company is a global pharmaceutical company headquartered in Indianapolis, Indiana. They are dedicated to developing and delivering innovative pharmaceutical products that help improve the lives of people around the world.
The graph shows the results of our forecasting system for LLY. You can view historical price data with some markers indicating where our system has been signaling and where the projected targets have been achieved. This demonstrates to what extent our system's forecasts have been justified in real market conditions.

We do not display all the achieved goals on the graph, you can get detailed information about the achieved goals in the corresponding section on this page

Access the LLY Forecast by QuantWave

Stock ticker: LLY
Name: ELI LILLY AND COMPANY
Sector: Healthcare
Investing Risk:
Forecast length:
Accuracy:
Average profit per target:
This product is currently unavailable for purchase. Refer to the forecast later

LLY Achieves Targets with Precision, as Predicted by QuantWave

Show news about the achieved forecast
Signal Date Signal Price Date Reached Price Reached Profit Direction
2022-04-29283.64 $2022-11-30363.7 $ 28.23%
2022-05-06288.27 $2022-11-30363.7 $ 26.17%
2022-05-16291.66 $2022-11-08358.37 $ 22.87%
2022-06-02294.63 $2023-04-21378.8 $ 28.57%
2022-06-10289.35 $2022-12-02367.31 $ 26.94%
2022-07-01316.33 $2023-05-01399.03 $ 26.14%
2022-07-08321.94 $2023-05-03423.98 $ 31.69%
2022-07-15323.05 $2023-05-03423.98 $ 31.24%
2022-07-22320.27 $2023-05-01399.03 $ 24.59%
2022-08-04297.9 $2023-05-03423.98 $ 42.32%
2022-11-25357.99 $2023-05-03423.98 $ 18.44%
2022-11-28358.49 $2023-05-03423.98 $ 18.27%
2022-11-29356.71 $2023-05-03423.98 $ 18.86%
2022-12-09353.81 $2023-05-03423.98 $ 19.83%
2022-12-12359.95 $2023-05-03423.98 $ 17.79%
2022-12-13351.53 $2023-05-03423.98 $ 20.61%
2022-12-14356.27 $2023-05-03423.98 $ 19.01%
2022-12-15352.85 $2023-05-03423.98 $ 20.16%
2022-12-16352.71 $2023-05-03423.98 $ 20.21%
2022-12-20352.49 $2023-05-03423.98 $ 20.28%
2022-12-22358.04 $2023-05-03423.98 $ 18.42%
2022-12-27357.62 $2023-05-03423.98 $ 18.56%
2022-12-28357.96 $2023-05-03423.98 $ 18.45%
2022-12-29359.72 $2023-05-03423.98 $ 17.86%
2022-12-30358.56 $2023-05-03423.98 $ 18.24%
2023-01-03357.73 $2023-05-03423.98 $ 18.52%
2023-01-04355.88 $2023-05-03423.98 $ 19.14%
2023-01-05351.78 $2023-05-03423.98 $ 20.52%
2023-01-06355.72 $2023-05-03423.98 $ 19.19%
2023-01-09342.87 $2023-05-03423.98 $ 23.66%
2023-01-10345.73 $2023-05-03423.98 $ 22.63%
2023-01-11353.24 $2023-05-03423.98 $ 20.03%
2023-02-03332.34 $2023-05-08425.49 $ 28.03%
2023-02-06330.94 $2023-05-03423.98 $ 28.11%
2023-02-07332.92 $2023-05-03423.98 $ 27.35%
2023-02-08333.95 $2023-05-10428.63 $ 28.35%
2023-02-09334.99 $2023-05-10428.63 $ 27.95%
2023-02-13343.43 $2023-05-10428.63 $ 24.81%
2023-02-14341.75 $2023-05-16430.47 $ 25.96%
2023-02-15329.41 $2023-05-16430.47 $ 30.68%
2023-02-17322.91 $2023-05-03423.98 $ 31.3%
2023-02-21322.03 $2023-05-03423.98 $ 31.66%
2023-02-22323.57 $2023-05-08425.49 $ 31.5%
2023-02-24316.26 $2023-05-03423.98 $ 34.06%
2023-02-28306.02 $2023-05-08425.49 $ 39.04%
2023-03-01308.92 $2023-05-10428.63 $ 38.75%
2023-03-02309.78 $2023-05-03423.98 $ 36.86%
2023-03-16324.02 $2023-05-03423.98 $ 30.85%
2023-03-21325.54 $2023-05-19436.12 $ 33.96%
2023-03-22325.44 $2023-05-19436.12 $ 34.01%
2023-03-24330.51 $2023-05-01399.03 $ 20.73%
2023-04-14368.46 $2023-08-08514.21 $ 39.56%
2023-04-17366.12 $2023-08-08514.21 $ 40.45%
2023-04-19364.28 $2023-06-30462.34 $ 26.92%
2023-04-20368.54 $2023-06-30462.34 $ 25.45%
2023-04-24376.94 $2023-08-08514.21 $ 36.42%
2023-04-25378.41 $2023-08-08514.21 $ 35.89%
2023-04-26369.98 $2023-08-08514.21 $ 38.98%
2023-04-27383.82 $2023-08-08514.21 $ 33.97%
2023-04-28389.24 $2023-08-08514.21 $ 32.11%
2023-05-01399.03 $2023-08-08514.21 $ 28.87%
2023-05-02397.44 $2023-08-08514.21 $ 29.38%
2023-05-04421.28 $2023-08-08514.21 $ 22.06%
2023-05-09421.22 $2023-08-08514.21 $ 22.08%
2023-05-10428.63 $2023-08-08514.21 $ 19.97%
2023-05-11428.27 $2023-08-08514.21 $ 20.07%
2023-05-12428.28 $2023-08-08514.21 $ 20.07%
2023-05-19436.12 $2023-08-08514.21 $ 17.91%
2023-05-24419.74 $2023-08-08514.21 $ 22.51%
2023-06-01430.31 $2023-08-08514.21 $ 19.5%
2023-06-09439.72 $2023-08-28547.25 $ 24.45%
2023-06-13439.41 $2023-08-14531.52 $ 20.96%
2023-08-14531.52 $2024-02-01653.68 $ 22.98%
2023-10-27553.48 $2024-02-01653.68 $ 18.1%
2023-10-31547.26 $2024-02-01653.68 $ 19.45%
2023-11-01547.78 $2024-02-01653.68 $ 19.33%
2023-11-14604.58 $2024-05-30809.52 $ 33.9%
2023-11-22589.01 $2024-02-05698.98 $ 18.67%
2023-11-28585.55 $2024-02-05698.98 $ 19.37%
2024-01-09619.09 $2024-06-06831.6 $ 34.33%
2024-01-16628.08 $2024-02-16775.42 $ 23.46%
2024-01-23623.24 $2024-06-07844.21 $ 35.45%
2024-01-30638.39 $2024-05-21797.71 $ 24.96%
2024-02-06697.82 $2024-06-10859.12 $ 23.11%

Access the LLY Forecast by QuantWave

This product is currently unavailable for purchase. Refer to the forecast later

The latest news about the achievement of forecasting results and global news about eli lilly and company


LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

LLYFebruary 25, 2025Major Stock Movement: Lilly to participate in TD Cowens 45th Annual Health Care Conference  ~2 min.

Eli Lilly and Company (LLY) has recently caught the attention of investors as it prepares to participate in the TD Cowens 45th Annual Health Care Conference....




Other QuantWave offers: